161 related articles for article (PubMed ID: 12969966)
21. TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction.
Ou D; Metzger DL; Wang X; Huang J; Pozzilli P; Tingle AJ
Diabetologia; 2002 Dec; 45(12):1678-88. PubMed ID: 12488957
[TBL] [Abstract][Full Text] [Related]
22. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
23. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
MacFarlane M; Cohen GM; Dickens M
Biochem J; 2000 May; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718
[TBL] [Abstract][Full Text] [Related]
24. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.
Uno K; Inukai T; Kayagaki N; Goi K; Sato H; Nemoto A; Takahashi K; Kagami K; Yamaguchi N; Yagita H; Okumura K; Koyama-Okazaki T; Suzuki T; Sugita K; Nakazawa S
Blood; 2003 May; 101(9):3658-67. PubMed ID: 12506034
[TBL] [Abstract][Full Text] [Related]
25. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
Zauli G; Rimondi E; Nicolin V; Melloni E; Celeghini C; Secchiero P
Blood; 2004 Oct; 104(7):2044-50. PubMed ID: 15213096
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M
J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112
[TBL] [Abstract][Full Text] [Related]
27. MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells.
Rozenfeld-Granot G; Toren A; Amariglio N; Nagler A; Rosenthal E; Biniaminov M; Brok-Simoni F; Rechavi G
Exp Hematol; 2002 May; 30(5):473-80. PubMed ID: 12031654
[TBL] [Abstract][Full Text] [Related]
28. [TNF-related apoptosis-inducing ligand signaling pathway and hematopoietic malignancies].
Qian J; Chen ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):472-7. PubMed ID: 12513753
[TBL] [Abstract][Full Text] [Related]
29. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis.
Felli N; Pedini F; Zeuner A; Petrucci E; Testa U; Conticello C; Biffoni M; Di Cataldo A; Winkles JA; Peschle C; De Maria R
J Immunol; 2005 Aug; 175(3):1464-72. PubMed ID: 16034083
[TBL] [Abstract][Full Text] [Related]
30. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
Pawlowski JE; Nesterov A; Scheinman RI; Johnson TR; Kraft AS
Anticancer Res; 2000; 20(6B):4243-55. PubMed ID: 11205254
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts.
Grzasko N; Dmoszynska A; Hus M; Soroka-Wojtaszko M
Haematologica; 2006 Mar; 91(3):386-9. PubMed ID: 16531263
[TBL] [Abstract][Full Text] [Related]
32. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.
Olsson A; Diaz T; Aguilar-Santelises M; Osterborg A; Celsing F; Jondal M; Osorio LM
Leukemia; 2001 Dec; 15(12):1868-77. PubMed ID: 11753607
[TBL] [Abstract][Full Text] [Related]
33. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells.
Yu R; Mandlekar S; Ruben S; Ni J; Kong AN
Cancer Res; 2000 May; 60(9):2384-9. PubMed ID: 10811114
[TBL] [Abstract][Full Text] [Related]
35. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
36. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.
Jupp OJ; McFarlane SM; Anderson HM; Littlejohn AF; Mohamed AA; MacKay RH; Vandenabeele P; MacEwan DJ
Biochem J; 2001 Nov; 359(Pt 3):525-35. PubMed ID: 11672426
[TBL] [Abstract][Full Text] [Related]
37. TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway.
Jurewicz A; Matysiak M; Andrzejak S; Selmaj K
Glia; 2006 Jan; 53(2):158-66. PubMed ID: 16206163
[TBL] [Abstract][Full Text] [Related]
38. 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin.
Ammirante M; Di Giacomo R; De Martino L; Rosati A; Festa M; Gentilella A; Pascale MC; Belisario MA; Leone A; Turco MC; De Feo V
Cancer Res; 2006 Apr; 66(8):4385-93. PubMed ID: 16618764
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway.
Secchiero P; Gonelli A; Mirandola P; Melloni E; Zamai L; Celeghini C; Milani D; Zauli G
Blood; 2002 Oct; 100(7):2421-9. PubMed ID: 12239152
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.
Hueber A; Aduckathil S; Kociok N; Welsandt G; Dinslage S; Kirchhof B; Esser PJ
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):551-6. PubMed ID: 12136286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]